Cecelia A Bellcross
Affiliation: Centers for Disease Control and Prevention
- Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography populationCecelia A Bellcross
Dean Health System and Department of Population Health Sciences, University of Wisconsin, Madison Wisconsin, USA
Genet Med 11:783-9. 2009..This study evaluated the reliability and accuracy of a "referral screening tool" designed for rapid identification of individuals at potential hereditary risk for breast/ovarian cancer...
- Awareness and utilization of BRCA1/2 testing among U.S. primary care physiciansCecelia A Bellcross
CDC, Atlanta, Georgia 30333, USA
Am J Prev Med 40:61-6. 2011..Testing for mutations in the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 (BRCA) has been commercially available since 1996...
- Recruiting women for a study on perceived risk of cancer: influence of survey topic salience and early versus late responseSteven Leadbetter
Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341 3717, USA
Prev Chronic Dis 10:E75. 2013..The main objective of this analysis was to examine survey responder status (ie, early vs late response) by sociodemographic characteristics and by salience of study variables among respondents...
- Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health systemCecelia A Bellcross
Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA
Genet Med 17:43-50. 2015..Evidence shows underutilization of cancer genetics services. To explore the reasons behind this underutilization, this study evaluated characteristics of women who were referred for genetic counseling and/or had undergone BRCA1/2 testing...
- Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referralCecelia A Bellcross
Emory University School of Medicine, Department of Human Genetics, Whitehead Building, Suite 301, 615 Michael Street, Atlanta, GA 30322, USA
Cancer Epidemiol Biomarkers Prev 22:728-35. 2013....
- Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiativeL Brannon Traxler
Department of Surgery, Emory University, Atlanta, GA, USA
Ann Surg Oncol 21:3342-7. 2014..The project addresses young women at increased risk for hereditary breast and ovarian cancer (HBOC) syndrome through outreach efforts...